Date: Friday, May 7, 2004
Time: 8:00 am - 7:00 pm
Place: Bridgewater Manor, Bridgewater, NJ

Organizer Committee

Dr. Yusheng Wu (Co-Chair), Schering-Plough Research Institute

Dr. Ling Su (Co-Chair), Hoffman-La Roche

Dr. Helen Feng (Treasurer), Wyeth

Dr. Min Li (SAPA President), Merck & Co.

Dr. John Hu (SAPA President Elect), Novartis

Dr. Charles Wang, Johnson & Johnson

Dr. Mingde Xia, Johnson & Johnson

Dr. Rick Xu, Hoffman-La Roche

Dr. Gen Li, Pfizer

8:00-8:50 am Registration

8:50-9:00 am Opening remark

9:00-9:50 am "Pharmacological Intervention in p53 Regulation by Small-Molecule Antagonists of MDM2"

Dr. Lubo Vassilev, Research Leader, Discovery Oncology, Hoffmann-La Roche

9:50-10:40 am " Bioinformatics Discovery of NPC1L1, a Transporter Critical for Intestinal Cholesterol Absorption and Ezetimibe Action"

Dr. Nicholas J. Murgolo, Senior Principal Scientist, Schering-Plough Research Institute

10:40-11:30 am "Preclinical Safety and ADME Evaluation in Drug Development"

Dr. Helen Han Hsu, Senior Director of Drug Evaluation-Toxicology/Pathology, Johnson & Johnson Pharmaceutical R&D.

11:30am-12:20 pm "Overview of product development"

Dr. Laman L. Alani, Executive Director, Pharmaceutical Research, Merck.

12:20-2:00 pm Lunch and Sponsor Hours

2:00-2:50 pm "The Role of Drug Metabolism Research in Drug Discovery and Development"

Dr. Anthony Y. H. Lu, Former Executive Director, Merck

2:50-3:40 pm " Strategic Planning in Clinical Development"

Dr. Bruce Lavin, Therapeutic Head - Respiratory & Anti-infectives/Medical Affaires, Aventis.

3:40-4:30 pm "Drug Regulation/Clinical Trial in China/TBD"

Dr. Hong Ma, Medical Director, Pfizer

4:30-4:40 pm Closing remarks

4:40-7:00 pm Reception

5:00 pm-7:00 pm Special Event for Roche R&D Center in China
"Introduction of Roche R&D Center in China and Job Fair"

Dr. Li Chen, Chief Scientific Officer, Roche R&D Center China